 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for...

Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

Shuttle Pharma Expands Patent Coverage on HDAC Inhibitor Platform Shuttle Pharma Expands Patent Coverage on HDAC Inhibitor Platform PR Newswire ROCKVILLE, Md., Sept. 11, 2023 ROCKVILLE, Md., Sept...

Shuttle Pharma Expands Patent Coverage on HDAC Inhibitor Platform

Shuttle Pharma's Selective HDAC6 Inhibitor Shown to Stimulate Innate Immune Response in Pre-clinical Studies, as Reported in Molecular Cancer Therapeutics Shuttle Pharma's Selective HDAC6 Inhibitor...

Shuttle Pharma's Selective HDAC6 Inhibitor Shown to Stimulate Innate Immune Response in Pre-clinical Studies, as Reported in Molecular Cancer Therapeutics

Shuttle Pharmaceuticals Provides Second Quarter 2023 Corporate Update Shuttle Pharmaceuticals Provides Second Quarter 2023 Corporate Update PR Newswire ROCKVILLE, Md., Aug. 15, 2023 ROCKVILLE, Md., Aug. 15, 2023 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and...

Shuttle Pharmaceuticals Provides Second Quarter 2023 Corporate Update

Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical Trial Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical Trial PR Newswire ROCKVILLE, Md., Aug. 3, 2023 ROCKVILLE, Md., Aug. 3...

Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical Trial

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
It's time to start off the week right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
The post Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on ...

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate Update Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate Update PR Newswire ROCKVILLE, Md., May 26, 2023 ROCKVILLE, Md., May 26, 2023 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and...

Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate Update

Shuttle Pharmaceuticals to Participate in the Lytham Partners Spring 2023 Investor Conference Shuttle Pharmaceuticals to Participate in the Lytham Partners Spring 2023 Investor Conference PR Newswire ROCKVILLE, Md., May 17, 2023 ROCKVILLE, Md., May 17, 2023 /PRNewswire/ -- Shuttle Pharmaceuticals...

Shuttle Pharmaceuticals to Participate in the Lytham Partners Spring 2023 Investor Conference

Shuttle Pharmaceuticals (NASDAQ:SHPH  Get Rating) lock-up period is set to expire on Monday, February 27th. Shuttle Pharmaceuticals had issued 1,225,888 shares in its initial public offering on August 31st. The total size of the offering was $9,966,469 based on an initial share price ...

Shuttle Pharmaceuticals Holdings, Inc.'s (NASDAQ:SHPH) Lock-Up Period Set To End  on February 27th

Shuttle Pharmaceuticals (NASDAQ:SHPH Get Rating) lock-up period will end on Monday, February 27th. Shuttle Pharmaceuticals had issued 1,225,888 shares in its initial public offering on August 31st. The total size of the offering was $9,966,469 based on an initial share price of $8.13. After the end ...

Shuttle Pharmaceuticals Holdings, Inc.'s (NASDAQ:SHPH) Lock-Up Period To Expire  on February 27th

Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.

Watchers	2,596
52-Wk Low	$0.5185
52-Wk High	$4.69

Market Cap	$9.44M
Volume (M)	23,810.00
52-Wk High	$4.69
52-Wk Low	$0.5185

SHPH Shuttle Pharmaceuticals Holdings Inc

About

Feed

News

Earnings

Fundamentals